Literature DB >> 28433839

The Diagnostic Accuracy of Evoked Potential Monitoring Techniques During Intracranial Aneurysm Surgery for Predicting Postoperative Ischemic Damage: A Systematic Review and Meta-Analysis.

Benjamin Thomas1, Dongsheng Guo2.   

Abstract

OBJECTIVE: To investigate the diagnostic accuracy of various evoked potential monitoring techniques in predicting postoperative neurologic deficit in intracranial aneurysm surgery.
METHODS: A literature search of the MEDLINE, Embase, and Cochrane databases was conducted for English language articles published between March 31, 1983 and March 31, 2016. Original studies that reported the use of evoked potential monitoring during intracranial aneurysm surgery in predicting postoperative neurologic damage were selected, and their relevant reference lists were hand searched. Test performance characteristics were summarized using hierarchic summary receiver operating characteristic (ROC) curves and bivariable random-effects models.
RESULTS: Thirteen qualifying studies (1597 patients; 1689 aneurysms) from 6 countries were identified. Eight studies investigated the use of the somatosensory evoked potential (SSEP) monitoring technique, 5 investigated transcranial motor evoked potential (TcMEP) and another 5 investigated direct cortical motor evoked potential (DMEP). Bivariable pooled sensitivity and specificity were 48% (95% confidence interval [CI], 30.7-65.0) and 92% (CI, 88%-94.4%), respectively, for SSEP; 73% (CI, 21.0%-96.7%) and 94% (CI, 87.1%-97.5%) for TcMEP; and 97% (CI, 74.43%-99.99%) and 89% (CI, 84.0%-94.5%) for DMEP. ROC curve analysis showed that TcMEP had the highest accuracy (area under ROC curve 0.95; 95% CI, 0.93-0.97), followed by DMEP (0.91, 0.89-0.94) and SSEP (0.88, 0.85-0.91).
CONCLUSIONS: TcMEP and DMEP have higher diagnostic accuracy than SSEP in predicting postoperative neurologic deficit. The type of anesthetic agent, the use of neuromuscular blocking drugs, and the choice of diagnostic criteria for significant change in cerebral blood flow during aneurysm surgery affect the diagnostic accuracy of evoked potential techniques in predicting postoperative neurologic deficit.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneurysm surgery; Cerebral; Evoked potential monitoring; Intracranial; Neurologic ischemia; Neurophysiologic monitoring; Sensitivity and specificity

Mesh:

Year:  2017        PMID: 28433839     DOI: 10.1016/j.wneu.2017.04.071

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

1.  Diagnostic impact of monitoring transcranial motor-evoked potentials to prevent ischemic complications during endovascular treatment for intracranial aneurysms.

Authors:  Ichiro Nakagawa; HunSoo Park; Masashi Kotsugi; Yasushi Motoyama; Kaoru Myochin; Yasuhiro Takeshima; Ryosuke Matsuda; Fumihiko Nishimura; Syuichi Yamada; Tsunenori Takatani; Kimihiko Kichikawa; Hiroyuki Nakase
Journal:  Neurosurg Rev       Date:  2020-06-23       Impact factor: 3.042

2.  Long non-coding RNA NORAD induces phenotypic regulation of vascular smooth muscle cells through regulating microRNA-136-5p-targeted KDM1A.

Authors:  Chao Lv; Jun Wang; Shuhui Dai; Yanwei Chen; Xiaofan Jiang; Xia Li
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 5.173

3.  Diagnostic Impact of Monitoring Visual Evoked Potentials to Prevent Visual Complications During Endovascular Treatment for Intracranial Aneurysm.

Authors:  Ichiro Nakagawa; HunSoo Park; Masashi Kotsugi; Shohei Yokoyama; Kouji Omoto; Kaoru Myochin; Yasuhiro Takeshima; Ryosuke Matsuda; Fumihiko Nishimura; Shuichi Yamada; Tsunenori Takatani; Hiroyuki Nakase
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

4.  Utility of evoked potentials during anterior cerebral artery and anterior communicating artery aneurysm clipping.

Authors:  Ferenc Rabai; Claire M Dorey; W Christopher Fox; Krista M Fitzgerald; Christoph N Seubert; Steven A Robicsek
Journal:  Clin Neurophysiol Pract       Date:  2022-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.